Evidence map›Paper›PMID 28122528›Full record

ArticleBMC cancer2017

A non-invasive tool for detecting cervical cancer odor by trained scent dogs.

Héctor Guerrero-Flores, Teresa Apresa-García, Ónix Garay-Villar, Alejandro Sánchez-Pérez, David Flores-Villegas, Artfy Bandera-Calderón, Raúl García-Palacios, Teresita Rojas-Sánchez, Pablo Romero-Morelos, Verónica Sánchez-Albor and 14 more

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Human Breathomics Database.Database : the journal of biological databases and curation · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 5 institutions in 1 country.

Héctor Guerrero-FloresCoordinación de Prevención y Atención a la Salud, Delegación Sur (Instituto Mexicano del Seguro Social) IMSS, Mexico City, Mexico.
Teresa Apresa-GarcíaLaboratorio de Oncología Genómica, Unidad de Investigación Médica en Enfermedades Oncológicas, UMAE Hospital de Oncología, CMN- SXXI-IMSS, Av. Cuauhtémoc 330, Col. Doctores, Del. Cuauhtémoc, 06720, Mexico City, Mexico.
Ónix Garay-VillarServicio de Braquiterapia, UMAE Hospital de Oncología, CMN-SXXI-IMSS, Mexico City, Mexico.
Alejandro Sánchez-PérezPEC de México, S.A. de C.V., Mexico City, Mexico.
David Flores-VillegasPEC de México, S.A. de C.V., Mexico City, Mexico.
Artfy Bandera-CalderónServicio de Oncología, Hospital General de Zona y de Medicina Familiar No. 5, IMSS, Taxco, Guerrero, Mexico.
Raúl García-PalaciosClínica de la Mujer y Medicina Perinatal, Col. Roma Norte, Mexico City, Mexico.
Teresita Rojas-SánchezCentro Colposcópico de Docencia e Investigación, A.C., Mexico, City, Mexico.
Pablo Romero-MorelosLaboratorio de Oncología Genómica, Unidad de Investigación Médica en Enfermedades Oncológicas, UMAE Hospital de Oncología, CMN- SXXI-IMSS, Av. Cuauhtémoc 330, Col. Doctores, Del. Cuauhtémoc, 06720, Mexico City, Mexico.
Verónica Sánchez-AlborLaboratorio de Oncología Genómica, Unidad de Investigación Médica en Enfermedades Oncológicas, UMAE Hospital de Oncología, CMN- SXXI-IMSS, Av. Cuauhtémoc 330, Col. Doctores, Del. Cuauhtémoc, 06720, Mexico City, Mexico.
Osvaldo MataLaboratorio de Oncología Genómica, Unidad de Investigación Médica en Enfermedades Oncológicas, UMAE Hospital de Oncología, CMN- SXXI-IMSS, Av. Cuauhtémoc 330, Col. Doctores, Del. Cuauhtémoc, 06720, Mexico City, Mexico.
Víctor Arana-ConejoLaboratorio de Oncología Genómica, Unidad de Investigación Médica en Enfermedades Oncológicas, UMAE Hospital de Oncología, CMN- SXXI-IMSS, Av. Cuauhtémoc 330, Col. Doctores, Del. Cuauhtémoc, 06720, Mexico City, Mexico.
Jesús Badillo-RomeroDepartamento de Anatomía Patológica, Hospital General de Zona Troncoso, Mexico City, Mexico.
Keiko TaniguchiLaboratorio de Oncología Genómica, Unidad de Investigación Médica en Enfermedades Oncológicas, UMAE Hospital de Oncología, CMN- SXXI-IMSS, Av. Cuauhtémoc 330, Col. Doctores, Del. Cuauhtémoc, 06720, Mexico City, Mexico.
Daniel Marrero-RodríguezLaboratorio de Oncología Genómica, Unidad de Investigación Médica en Enfermedades Oncológicas, UMAE Hospital de Oncología, CMN- SXXI-IMSS, Av. Cuauhtémoc 330, Col. Doctores, Del. Cuauhtémoc, 06720, Mexico City, Mexico.
Mónica Mendoza-RodríguezLaboratorio de Oncología Genómica, Unidad de Investigación Médica en Enfermedades Oncológicas, UMAE Hospital de Oncología, CMN- SXXI-IMSS, Av. Cuauhtémoc 330, Col. Doctores, Del. Cuauhtémoc, 06720, Mexico City, Mexico.
Miriam Rodríguez-EsquivelLaboratorio de Oncología Genómica, Unidad de Investigación Médica en Enfermedades Oncológicas, UMAE Hospital de Oncología, CMN- SXXI-IMSS, Av. Cuauhtémoc 330, Col. Doctores, Del. Cuauhtémoc, 06720, Mexico City, Mexico.
Víctor Huerta-PadillaLaboratorio de Oncología Genómica, Unidad de Investigación Médica en Enfermedades Oncológicas, UMAE Hospital de Oncología, CMN- SXXI-IMSS, Av. Cuauhtémoc 330, Col. Doctores, Del. Cuauhtémoc, 06720, Mexico City, Mexico.
Andrea Martínez-CastilloLaboratorio de Oncología Genómica, Unidad de Investigación Médica en Enfermedades Oncológicas, UMAE Hospital de Oncología, CMN- SXXI-IMSS, Av. Cuauhtémoc 330, Col. Doctores, Del. Cuauhtémoc, 06720, Mexico City, Mexico.
Irma Hernández-GallardoCoordinación de Prevención y Atención a la Salud, Delegación Sur (Instituto Mexicano del Seguro Social) IMSS, Mexico City, Mexico.
Ricardo López-RomeroLaboratorio de Oncología Genómica, Unidad de Investigación Médica en Enfermedades Oncológicas, UMAE Hospital de Oncología, CMN- SXXI-IMSS, Av. Cuauhtémoc 330, Col. Doctores, Del. Cuauhtémoc, 06720, Mexico City, Mexico.
Cindy BandalaDivisión de Neurociencias, Instituto Nacional de Rehabilitación (INR), Secretaría de Salud (S.S.), Mexico City, Mexico.
Juan Rosales-GuevaraFacultad de Química, Universidad La Salle, Mexico City, Mexico.
Mauricio SalcedoLaboratorio de Oncología Genómica, Unidad de Investigación Médica en Enfermedades Oncológicas, UMAE Hospital de Oncología, CMN- SXXI-IMSS, Av. Cuauhtémoc 330, Col. Doctores, Del. Cuauhtémoc, 06720, Mexico City, Mexico. maosal89@yahoo.com.
Mexican Social Security Institute · MXHospital General De Zona · MXInstituto Nacional de las Mujeres · MXInstituto Nacional de Rehabilitación · MXUniversidad La Salle · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCervical Cancer (CC) has become a public health concern of alarming proportions in many developing countries such as Mexico, particularly in low income sectors and marginalized regions. As such, an early detection is a key medical factor in improving not only their population's quality of life but also its life expectancy. Interestingly, there has been an increase in the number of reports describing successful attempts at detecting cancer cells in human tissues or fluids using trained (sniffer) dogs. The great odor detection threshold exhibited by dogs is not unheard of. However, this represented a potential opportunity to develop an affordable, accessible, and non-invasive method for detection of CC.

methodsUsing clicker training, a male beagle was trained to recognize CC odor. During training, fresh CC biopsies were used as a reference point. Other samples used included cervical smears on glass slides and medical surgical bandages used as intimate sanitary pads by CC patients. A double-blind procedure was exercised when testing the beagle's ability to discriminate CC from control samples.

resultsThe beagle was proven able to detect CC-specific volatile organic compounds (VOC) contained in both fresh cervical smear samples and adsorbent material samples. Beagle's success rate at detecting and discriminating CC and non-CC odors, as indicated by specificity and sensitivity values recorded during the experiment, stood at an overall high (>90%). CC-related VOC in adsorbent materials were detectable after only eight hours of use by CC patients.

conclusionPresent data suggests different applications for VOC from the uterine cervix to be used in the detection and diagnosis of CC. Furthermore, data supports the use of trained dogs as a viable, affordable, non-invasive and, therefore, highly relevant alternative method for detection of CC lesions. Additional benefits of this method include its quick turnaround time and ease of use while remaining highly accurate and robust.

Indexed as

AnimalsBiomarkers, TumorDogsDouble-Blind MethodEarly Detection of CancerFemaleHumansMaleOdorantsSensitivity and SpecificityUterine Cervical NeoplasmsBiomarkers, Tumor

Identifiers

PMID28122528
PMCPMC5267360
OpenAlexW2581187728

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.